Results of a 10-year follow-up study of breast cancer patients who had been treated with accelerated partial breast irradiation after surgery demonstrated that the rates of recurrence were similar to those of patients who were treated with whole breast irradiation. Based on these findings, accelerated partial breast irradiation should be considered a reasonable alternative for whole breast irradiation in early breast cancer patients.
A total of 520 women aged >40 years with stage 1 or stage 2 breast cancer (with a maximum pathological tumour size of 25 mm and final surgical margins ≥5 mm) were included in the randomised phase 3 APBI IMRT trial . Between 2005 and 2013, the patients were randomly assigned in a 1:1 ratio to receive either accelerated partial breast irradiation or whole breast irradiation. The patients in the accelerated partial breast irradiation arm (n=260) received a total of 30 Gray (Gy) of radiation to the tumour bed in 5 daily fractions; p...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Better outcomes with oral paclitaxel than intravenous paclitaxel in metastatic breast cancer Next Article
HER2 antibody-drug conjugate T-DXd promising in T-DM1 pretreated patients »
Table of Contents: SABCS 2019
Screening, Detection, and Diagnosis
Phase 2 Trial Update
Phase 3 Trial Update
Long-Term Study Results
Triple-Negative Breast Cancer
HER2-Positive Breast Cancer
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.